Posted by Matthew Steigler on Oct 1st, 2024
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 19,610,000 shares, an increase...
More of this article »